How to Choose a 12-Lead Electrocardiograph for a Healthcare Facility

At first glance, the process seems straightforward: identify the patient, place the electrodes, record the ECG and send it for review. Then the trace arrives full of noise, a patient detail is missing, the network stops responding or no one can confirm whether the study was actually archived.

Choosing a 12-lead electrocardiograph is therefore not simply a matter of comparing screens, algorithms or print speeds. The device must work within a specific care pathway, with its own staff, systems, timings and everyday disruptions.

A device can produce a technically sound signal and still be a poor fit for the facility. The reverse is also true: a seemingly minor feature—clearer identification, an understandable alert or straightforward recovery after a network failure—may prevent more problems than several headline specifications.

Purchasing starts before opening the catalogue

The first question should not be “Which model has the most features?”, but “What needs to happen from the moment an ECG is requested until the trace has been reviewed and archived?”

That journey differs considerably between a practice with scheduled appointments, a Primary Care centre and a hospital where several departments share equipment. Volume, mobility, urgency, patient identification and the consequences of an interruption all change.

The setting determines which features deliver real value

The table helps structure the discussion, but it is no substitute for direct observation. Two hospitals with a similar workload may need different configurations if one uses electronic orders and the other enters data manually.

In Primary Care, moreover, the ECG forms part of a broader equipment strategy. Equimed’s guide to medical equipment for Primary Care places it within the wider set of resources required by a modern consultation room.

The ELI® 280 distributed by Equimed is designed for settings ranging from a medical practice to a hospital. It has a 10.1-inch touchscreen capable of displaying all twelve leads and offers two acquisition options: the wireless WAM™ module and the traditional AM12™ module.

These features may be relevant, but they do not carry the same weight in every facility. Wireless acquisition can make it easier to move around the patient; elsewhere, a stable traditional configuration may be entirely sufficient.

Equimed also provides detailed technical information about the ELI® 280. This guide takes a different approach: it explains how product capabilities can be translated into a defensible technical decision.

ECG quality depends on a chain, not a single specification

When an artefact appears, it is tempting to attribute it to the device immediately. Yet signal quality also depends on skin preparation, electrode placement, cable condition, patient movement, interference and the experience of the person performing the acquisition.

It is therefore important to see what support the electrocardiograph provides before a recording is confirmed:

• simultaneous display of all leads;
• connection status indicators;
• clear, understandable alerts;
• the ability to review the trace before transmission;
• identification of situations that require electrode placement to be corrected;
• tools that help select a cleaner segment with less noise.

The available ELI® 280 documentation describes simultaneous acquisition of all twelve leads, connection confirmation and lead-reversal detection. It also includes the Best 10 function, which evaluates the stored signal and selects ten seconds with a lower level of noise.

This function may help reduce avoidable reviews or repeated recordings, but it cannot correct poor patient preparation. The same applies to the VERITAS® algorithm: it is a decision-support tool, not a substitute for clinical judgement. The technical data sheet available from Equimed states that its interpretations must be considered alongside medical review and the patient’s other relevant clinical information.

Equimed’s article explaining what an electrocardiogram is and why it matters provides useful clinical context for this starting point.

A useful demonstration should put the device under pressure

A flawless demonstration is of limited value if everything has been prepared in advance: the patient is already identified, the connection is stable, the recording is clean and the destination is configured.

A twenty-minute test can reveal more than twenty pages

1. Switch on the device and sign in with the usual user profile.
2. Find or create a patient using the intended procedure.
3. Prepare the acquisition and check the status of the leads.
4. Simulate a simple incident, such as a disconnected cable or a noisy signal.
5. Review and correct the recording without restarting the entire process.
6. Confirm the ECG and send it to its destination.
7. Check what information is received by the professional responsible for reviewing it.
8. Temporarily interrupt the connection and observe how it recovers.
9. Prepare the device for the next patient.
10. Repeat part of the test with a different professional profile.

Compare devices using the same criteria

“Connectable” does not mean “integrated”

Acronyms such as DICOM®, HL7®, XML and PDF provide useful information, but they do not solve integration on their own. Before assessing a proposal, the facility needs to know where the device obtains patient identity, where the ECG is archived, how successful transmission is confirmed, what happens when the network is unavailable and which licences are required.

Official information about the ELI® 280 describes bidirectional communication via LAN or wireless LAN and compatibility with third-party EHR, PACS and CVIS systems through XML, PDF, DICOM® and HL7®. These are relevant capabilities, but they must be verified within the facility’s specific architecture.

An integration test should use controlled identifiers and orders, verify the match between patient and trace, and document the behaviour of an incomplete transmission. The result should leave no uncertainty about which system is the source of identity and which is the final clinical archive.

When the network fails, the ECG should not disappear into a grey area

The user needs to know whether the recording remains stored, how it is identified as pending, who can resend it and what confirmation is provided when it finally reaches its destination. If the answer is “The network does not normally fail”, the evaluation is incomplete.

Security also matters at the screen

An ECG contains both clinical and identifying information. Individual authentication, user profiles, session timeout, traceability, local records, communication protection, updates and secure device decommissioning should all be checked.

The ELI® 280 technical data sheet describes centralised access controls via LDAP or Active Directory and encryption of protected information both at rest and in transit. Before including these functions in a specification, confirm the version, licences and compatibility with the current infrastructure.

This dimension should be reviewed jointly by clinical teams, IT, information security and clinical engineering. A feature listed in the documentation only becomes a safeguard when it has been configured, tested and assigned to a responsible owner.

The purchase price is often the smallest line in the calculation

An electrocardiograph will remain in service for years. During that time, it will require cables, electrodes, paper where used, batteries, cleaning, training, maintenance, updates and support.

What the total cost of ownership should include

The financial comparison should cover the same period and the same level of service for every proposal. Responsibilities for maintenance, replacement, updates and support continue long after installation, so they should be agreed before the purchase.

The decision does not belong to a single department

Procurement can compare commercial terms, but it should not decide how a patient is identified. IT can validate an interface, but not whether the workflow is practical during an on-call shift. Cardiology can assess the trace, but may not know how quickly a damaged cable can be replaced.

• Professional users: acquisition, ergonomics and understanding of alerts.
• Cardiology or medical leadership: suitability for the intended use and clinical review.
• Clinical engineering: maintenance, accessories and lifecycle.
• IT: identity, interfaces, archive, security and recovery.
• Infection prevention: cleaning and product compatibility.
• Procurement: terms, supply, warranties and total cost.

Warning signs during the evaluation

Eight questions that improve any specification

1. In which locations, and at what volume, will the device be used?
2. Who identifies the patient, and where do those details come from?
3. Which controls help detect problems before the ECG is confirmed?
4. How does the recording reach the professional responsible for reviewing it?
5. What happens if the network, battery or an accessory fails?
6. Which security configuration does the facility require?
7. Which costs and responsibilities will arise over the device’s useful life?
8. What evidence will demonstrate that the device has passed acceptance testing?

Choosing well means reducing uncertainty

The best 12-lead electrocardiograph is not necessarily the one with the longest feature list. It is the one that enables an appropriate recording to be acquired, identified correctly, reviewed, transmitted and recovered within the facility’s real care pathway.

Turning everyday situations into tests, responsibilities and evidence makes it possible to compare proposals more rigorously. It also prevents the most important problems from appearing after the purchase, when they are more expensive and difficult to correct.